Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

May-Lucie Meyer

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of the American Medical Directors Association|March 31, 2021
Slowness Predicts Mortality: A Comparative Analysis of Walking Speed and Moberg Picking-Up TestsMay-Lucie Meyer, Sarah Fustinoni, Yves Henchoz, et al.
The Oncologist|October 6, 2025
Antibody drugs conjugates in non-small cell lung cancer: current status and challengesArjun Syal, May-Lucie Meyer, Kenneth Angelino, et al.
Revue Medicale Suisse|May 18, 2022
[Adverse effects of new breast cancer therapies : when to react ?]Nassim Dris, May-Lucie Meyer, Camila Flores Torres, et al.
The Oncologist|October 6, 2025
Antibody drugs conjugates in small-cell lung cancer: present-day status and promisesArjun Syal, May-Lucie Meyer, Kenneth Angelino, et al.
Lancet (London, England)|August 9, 2024
New promises and challenges in the treatment of advanced non-small-cell lung cancerMay-Lucie Meyer, Bailey G Fitzgerald, Luis Paz-Ares, et al.
Critical Reviews in Oncology/Hematology|May 30, 2024
Rediscovering immunohistochemistry in lung cancerAnna La Salvia, May-Lucie Meyer, Fred R Hirsch, et al.
HIV Medicine|November 3, 2025
Quality improvement report: Investigating barriers in HIV testing oncology patients to optimize HIV testing practiceKatharine E A Darling, José Damas, Ana Leni Frei, et al.
Clinical Lung Cancer|September 27, 2024
Brief Report: Targeted Therapies and Pancreatitis in Patients With Advanced Nonsmall Cell Lung CancerMay-Lucie Meyer, Louis Gros, Natalie Décosterd, et al.
JTO Clinical and Research Reports|January 8, 2026
Gut Dysbiosis as a Potential Guide for Immunotherapy (Dis)Continuation After 2 Years in NSCLC: A Brief ReportAdele Bonato, Claudia Parisi, Priscilla Cascetta, et al.
International Journal of Public Health|February 6, 2026
Eligibility for Lung Cancer Screening in Switzerland: A Comparative Analysis of Three Data Sources From Lausanne and the Canton of VaudLouis Gros, Cynthia Schneider, May-Lucie Meyer, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of the American Medical Directors Association|March 31, 2021
Slowness Predicts Mortality: A Comparative Analysis of Walking Speed and Moberg Picking-Up TestsMay-Lucie Meyer, Sarah Fustinoni, Yves Henchoz, et al.
The Oncologist|October 6, 2025
Antibody drugs conjugates in non-small cell lung cancer: current status and challengesArjun Syal, May-Lucie Meyer, Kenneth Angelino, et al.
Revue Medicale Suisse|May 18, 2022
[Adverse effects of new breast cancer therapies : when to react ?]Nassim Dris, May-Lucie Meyer, Camila Flores Torres, et al.
The Oncologist|October 6, 2025
Antibody drugs conjugates in small-cell lung cancer: present-day status and promisesArjun Syal, May-Lucie Meyer, Kenneth Angelino, et al.
Lancet (London, England)|August 9, 2024
New promises and challenges in the treatment of advanced non-small-cell lung cancerMay-Lucie Meyer, Bailey G Fitzgerald, Luis Paz-Ares, et al.
Critical Reviews in Oncology/Hematology|May 30, 2024
Rediscovering immunohistochemistry in lung cancerAnna La Salvia, May-Lucie Meyer, Fred R Hirsch, et al.
HIV Medicine|November 3, 2025
Quality improvement report: Investigating barriers in HIV testing oncology patients to optimize HIV testing practiceKatharine E A Darling, José Damas, Ana Leni Frei, et al.
Clinical Lung Cancer|September 27, 2024
Brief Report: Targeted Therapies and Pancreatitis in Patients With Advanced Nonsmall Cell Lung CancerMay-Lucie Meyer, Louis Gros, Natalie Décosterd, et al.
JTO Clinical and Research Reports|January 8, 2026
Gut Dysbiosis as a Potential Guide for Immunotherapy (Dis)Continuation After 2 Years in NSCLC: A Brief ReportAdele Bonato, Claudia Parisi, Priscilla Cascetta, et al.
International Journal of Public Health|February 6, 2026
Eligibility for Lung Cancer Screening in Switzerland: A Comparative Analysis of Three Data Sources From Lausanne and the Canton of VaudLouis Gros, Cynthia Schneider, May-Lucie Meyer, et al.
Pageof 2